Assessing measures of comorbidity using National Health Insurance Databases

Taiwan Journal of Public Health

Volumn 29, Issue 3, 2010, Pages 191-200

  Chu, Yu Tseng ^a,b   Wu, Shiao Chi ^b   Lee, Yu Chun ^b   Lai, Mei Shu ^a   Tam, Sing Chew ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Administrative data; CCI(Charlson Comorbidity Index); Claim data; Comorbidity

Indexed keywords

EID: 77956571007     PISSN: 10232141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993;32:382-7. (Pubitemid 24001924)
2. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9CM administrative databases. J Clin Epidemiol 1992;45:613-9.
3. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27. (Pubitemid 128456396)
4. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med 1997;127:666-74.
5. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-9.
6. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000;29:891-8.
7. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970;23:455-68.
8. Kane RL. Understanding Health Care Outcomes Research. Gaithersburg: Aspen Publishers, 1997.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
10. Clark DO, Korff MV, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995;33:783-95.
11. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001 ;154:854-64. (Pubitemid 33000813)
12. Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 2003;38:1103-20. (Pubitemid 37048302)
13. Stukenborg GJ, Wagner DP, Connors Jr AF. Comparison of the performance of two comorbidity measures, with and without information from prior hospitalizations. Med Care 2001;39:727-39.
14. Charlson ME. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: a response. J Clin Epidemiol 1993;46:1083-4.
15. Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Med Care 2006;44:745-53.
16. Southern DA, Quan H, Ghali WA. Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care 2004;42:355-60.
17. Wang PS, Walker A, Tsuang M, Orav EJ, Levin R, Avorn J. Strategies for improving comorbidity measures based on Medicare and Medicaid claims data. J Clin Epidemiol 2000;53:571-8. (Pubitemid 30394506)
18. Radley DC, Gottlieb DJ, Fisher ES, Tosteson ANA. Comorbidity risk-adjustment strategies are comparable among persons with hip fracture. J Clin Epidemiol 2008;61:580-7.
19. Menendez R, Ferrando D, Valles JM, Martinez E, Perpina M. Initial risk class and length of hospital stay in community-acquired pneumonia. Eur Respir J 2001;18:151-6. (Pubitemid 32717443)
20. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-63.
21. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-84. (Pubitemid 37187367)
22. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 2004;10:467-72. (Pubitemid 39626775)
23. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum 2005;53:666-72.
24. Alan A. Categorical Data Analysis. 2 ed., Hoboken: John Wiley & Sons, Inc, 2002.
25. Iezzoni LI. Risk Adjustment for Measuring Health Care Outcomes. 3rd ed., Chicago: Health Administration Press, 2003.
26. Johnston JA, Wagner DP, Timmons S, Welsh D, Tsevat J, Render ML. Impact of different measures of comorbid disease on predicted mortality of intensive care unit patients. Med Care 2002;40:929-40.
27. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9. (Pubitemid 27028925)
28. Schneeweiss S, Wang PS, Avorn J, Maclure M, Levin R, Glynn RJ. Consistency of performance ranking of comorbidity adjustment scores in Canadian and US utilization data. J Gen Intern Med 2004;19:444-50. (Pubitemid 38638905)
29. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-20.
30. Glynn RJ, Monane M, Gurwitz JH, Choodnovskiy I, Avorn J. Aging, comorbidity, and reduced rates of drug treatment for diabetes mellitus. J Clin Epidemiol 1999;52:781-90. (Pubitemid 29361454)
31. Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol 1994;47:1191-9.